Table 2

Adverse events (AEs) related to study drug during the randomised treatment period

No. of patients (%)Etanercept (n=12)Placebo (n=12)
All AEs11 (91.7)11 (91.7)
Related AEs10 (83.3)6 (50.0)
Serious AEs1 (8.3)0 (0.0)